Fibromyalgia Treatment Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027
The Global Fibromyalgia Treatment Market size is expected to reach USD 1,414.4 million by 2027, exhibiting a CAGR of 9% during the forecast period 2021-2027.
Fibromyalgia is a common and complex chronic pain disorder that causes musculoskeletal pain, fatigue, and local tenderness that affect individuals mentally, physically, and socially. Fibromyalgia is mainly caused by genetic conditions, but the actual cause is still unknown. The most common symptoms of fibromyalgia are fatigue, sleep problems, chronic muscle pain, and tenderness. People with fibromyalgia may also have symptoms such as headaches, difficulty concentrating, and depression. Fibromyalgia symptoms can build up over time or be caused by some external factors. Treatment for fibromyalgia includes therapy, medications, regular aerobic exercise, and stress reduction. Antidepressants or pain relievers are also prescribed to treat depression, anxiety, pain, and fatigue for the treatment of fibromyalgia.
Market Segments
Based on drug class
- Antidepressants
- Anticonvulsants
- Muscle Relaxants
- Analgesics
Based on distribution channels
- Hospitals Pharmacies
- Drug Stores
- Retail Pharmacies
- Online Pharmacies
Key Players
Some of the key players in the fibromyalgia treatment market are Pfizer, GlaxoSmithKline, AstraZeneca, F. Hoffmann-La Roche AG, Astellas Pharma, Johnson & Johnson Services, Inc., SANOFI, Eli Lilly and Company, Bayer AG, ALLERGAN, Boehringer Ingelheim, AbbVie, Cephalon, Inc., Sunovion Pharms Inc, Jazz Pharmaceuticals, Vertical Pharmaceuticals, ABBOTT, NOVARTIS, and others.
Scope of the Report
The research study analyzes the global Fibromyalgia Treatment industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by Fibromyalgia Treatment Market Report
1. What was the Fibromyalgia Treatment Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).
2. What will be the CAGR of the Fibromyalgia Treatment Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Fibromyalgia Treatment Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report will be delivered within 48-72 hours after payment confirmation